Boston Harbor Angels

Boston, Massachusetts, United StatesFounded 2004

SaaS Biotech & Life Sciences Healthcare Consumer Fintech AI Climate & Energy Robotics & Automation Enterprise Software Data & Analytics

Boston Harbor Angels is a group of proven business leaders who invest personal capital in high-growth, early-stage companies, typically raising $250K to $1.5M. Founded in 2004, the group invests across a broad range of sectors including information technology, life sciences, consumer products, medical devices, and clean technology, providing both funding and mentorship to entrepreneurs.

32% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $5.9M (across 18 rounds with reported amounts).

Find people at Boston Harbor Angels on Goldilocks AI

Portfolio

Fund Size

—

Top Stage

Seed

Last 12 Mo

Team

Antonette Ho

Managing Director

Marcos Bento

Head of Investment

Anthony Gellert

Head of Syndication

Jason Kraus

Head of Ecosystem Relations

Kristin King

Head of Group Management

Leslie Moukheiber

Operations Manager

Ziad Moukheiber

President and CEO

Portfolio Breakdown

Stage Distribution

Sector Distribution

Investment Activity

DealsAvg Round Size

Portfolio

19 investments

Company	Round	Amount	Valuation	Date
Zylö Therapeutics	Series B	$5.2M	—	Jun 2022
Xeno Biosciences	Series A	$7.3M	—	Jan 2021
Astrocyte	Seed	$2.4M	—	Jul 2017
Astrocyte	Seed	$1.4M	—	Jan 2017
DDaktari Diagnostics	Series D	$15.5M	—	Mar 2015
Pixability	Unknown	$8.1M	—	Jun 2014
Pixability	Series C	$18M	—	Jan 2014
Avaxia	Series A	$4.1M	—	Feb 2012
Avaxia	Series A	$2.2M	—	Nov 2011
VVizibility	Seed	$1.3M	—	Aug 2011
Pixability	Unknown	$1M	—	Feb 2011
DDaktari Diagnostics	Seed	$10M	—	Jan 2011
Pixability	Unknown	$1M	—	Jan 2011
VVizibility	Seed	$1M	—	Nov 2010
Zylö Therapeutics	Series A	—	—	—
AArcher Roose	Unknown	$6M	—	—
S'More Date	Seed	$3.2M	—	—
SSiamab Therapeutics	Series B	$12M	—	—
Archer Roose Wines	Unknown	$6M	—	—